Artificial NS4 mosaic antigen of hepatitis C virus

Journal of Medical Virology

Volumn 59, Issue 4, 1999, Pages 437-450

  Chang, J C ^a   Ruedinger, B ^a   Cong, M ^a   Lambert, S ^a,d   Lopareva, E ^a   Purdy, M ^a   Holloway, B P ^b   Jue, D L ^b   Ofenloch, B ^c   Fields, H A ^a   Khudyakov, Y E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^c Boehringer GmbH   (Germany)

^d Labcorp Drug Development   (United States)

Author keywords

Antigens; HCV; Peptides; Recombinant proteins; Sequence specific antibodies

Indexed keywords

NS4 ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ARTICLE; DIAGNOSTIC VALUE; GENE EXPRESSION; GENE SEQUENCE; HEPATITIS C VIRUS; IMMUNOREACTIVITY; NUCLEOTIDE SEQUENCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION; GENES, SYNTHETIC; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0032738014     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199912)59:4<437::AID-JMV4>3.0.CO;2-5     Document Type: Article

References (62)

1. Adams NJ, Chamberlain RW, Taylor, LA, Davidson F, Lin CK, Elliott RM, Simmonds P. 1997. Complete coding sequence of hepatitis C virus genotype 6a. Biochem Biophys Res Commun 234:393-396.
2. Aichele P, Hengartner H, Zinkernagel RM, Schult M. 1990. Anticytoxic T-cell response induced by in vivo priming with a free synthetic peptide. J Exp Med 171:1815-1820.
3. Alonso C, Qu D, Lamelin JP, De Sanjose S, Vitvitski L, Li J, Berby F, Lambert V, Cortey ML, Trepo C. 1994. Serological responses to different genotypes of hepatitis C virus in France. J Clin Microbiol 32:211-212.
4. Barany G, Merrifield RB. 1980. The Peptides (E. Gross and J. Meienhofer, editors). New York: Academic Press, p 1-284.
5. Berasain C, Garcia-Granero M, Riezu-Boj J, Civeira MP, Prieto J, Borras-Cuesta F. 1993. Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides. J Hepatol 18:80-84.
6. Bhattacherjee V, Prescott LE, Pike I, Rodgers B, Bell H, El-Zayadi AR, Kew MC, Conradie J, Lin CK, Marsden H, Saeed AA, Parker D, Yap P-L, Simmonds P. 1995. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5, and 6. J Gen Virol 76:1737-1748.
7. Bukh J, Purcell RH, Miller RH. 1993. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci USA 90: 8234-8238.
8. Bukh J, Miller RH, Purcell RH. 1995. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 15:41-63.
9. Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliott RM. 1997. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the middle east. J Gen Virol 78:1341-1347.
10. Chan SW, Simmonds P, McOmish F, Yap PL, Mitchell R, Dow B, Follett E. 1991. Serological responses to infection with three different types of hepatitis C virus. Lancet 338:1391.
11. Chang JC, Seidel, C, Ofenloch, B, Jue DL, Fields, HA, Khudyakov, YE. 1999. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides. Virology 257:177-190.
12. Chiba J, Ohba H, Matsuura Y, Atanabe Y, Katayama T, Kikuchi S, Saito I, Miyamura T. 1991. Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus. Proc Natl Acad Sci USA 88:4641-4645.
13. Chien DY, Choo QL, Tabrizi A, Huo C, McFarland J, Berger K, Lee C, Shuster JR, Nguyen T, Moyer DL, Tong M, Furuta S, Omata M, Tegteier G, Alter H, Schiff E, Jeffers L, Houghton M, Kuo G. 1992. Diagnosis of hepatitis C virus (HCV) infection using an immunodominat chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci USA 89:10011-10015.
14. Choo Q, Kuo G, Weiner A, Overby L, Bradley D, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
15. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby A, Barr P, Weiner AJ, Bradley DW, Kuo G, Houghton M. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451-2455.
16. Dhaliwal SK, Prescott LE, Dow BC, Davidson F, Brown H, Yap PL, Follett EAV, Simmonds P. 1996. Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. J Med Virol 48:184-190.
17. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock. 1994. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 19:13-18.
18. Fujinami RS, Oldstone MBA. 1989. Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res 8:3-15.
19. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice C. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67:1385-1395.
20. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. 1991. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 175:220-228.
21. Hosein B, Fang CT, Popovsky MA, Ye J, Zhang M, Wang CY. 1991. Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci USA 88: 3647-3651.
22. Houghton M, Weiner A, Han J. 1991. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 14:381-388.
23. Inoue Y, Suzuki R, Matsuura Y, Harda S, Chiba J, Eatanabe Y, Saito I, Miyamura T. 1992. Expression of the amino-terminal half of the NS1 region of the hepatitis C virus genome and detection of an antibody to the expressed protein in patients with liver diseases. J Gen Virol 73:2151-2154.
24. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 87:9524-9528.
25. Khudyakov YE, Favorov MO, Khudyakov NS, Cong M, Holloway BP, Padhye N, Lambert SB, Jue DL, Field HA. 1994. Artificial mosaic protein containing antigentic epitopes of hepatitis E virus. J Virol 68:7067-7074.
26. Khudyakov YE, Khudyakova NS, Jue DL, Lambert SB, Fang S, Fields HA. 1995. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. Virology 206: 666-672.
27. Kumar V, Bansal VJ, Rao VS, Jameel S. 1992. Hepatitist B virus envelope epitopes: gene assembly and expression in Escherichia coli of an immunological reactive novel multipleepitope polypeptide 1 (MEP-1). Gene 110:137-144.
28. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeter GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M. 1989. An assay for circulating antibodies to a major etiologic virus of human non-Am non-B hepatitis. Science 244:362-364.
29. Lok AS, Chien D, Choo QL, Chan TM, Chiu EK, Cheng IK, Houghton M, Kuo G. 1993. Antibodyresponse to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology 18:497-502.
30. Machida A, Ohnuma H, Tsuda F, Munekata E, Tanaka T, Akahane Y, Okamoto H, Mishiro S. 1992. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology 16: 886-891.
31. McOmish F, Chan SW, Dow BC, Gillon J, Frame WD, Crawford RJ, Yap PL, Follett EAC, Simmonds P. 1993. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 33:7-13.
32. McOmish F, Yap L, Dow BC, Follett EAC, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen E, Lin C, Lai C, Leong S, Medgyesi GA, Hejjas M, Kiyokawa H, Fukada K, Cuypers T, Saeed AA, Al-Rasheed AM Lin M, Simmonds P. 1994. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 32:884-892.
33. Miller RH, Purcell RH. 1990. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus subgroups. Proc Natl Acad Sci USA 87:2059-2061.
34. Mori S, Ohkoshi S, Hijikata M, Kato N, Shimotohno K. 1992. Serodiagnostic assay of hepatitis C virus infection using viral protease expressed in Escherichia coli. Jpn J Cancer Res 83:264-268.
35. Muraiso K, Hijikata M, Ohkoshi S, Cho MJ, Kikuchi M, Kato N, Shimotohno K. 1990. A structural protein of hepatitis C virus expressed in E. coli facilitates accurate detection of hepatitis C virus. Biochem Biophys Res Commun 172: 511-516.
36. Nagayama R, Tsuda F, Okamoto H, Wang Y, Mitsui T, Tanaka T, Miyakawa Y, Mayumi M. 1993. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunobsorbent assay with C 100-3 protein. J Clin Invest 92:1529-1533.
37. Nasoff MS, Zebedee SL, Inchauspe G, Prince AM. 1991. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci USA 88:5462-5466.
38. Okamoto H, Kurai K, Okada S, Yamamoto K, Lizuka H, Tanaka T. 1992) Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 88:331-334.
39. Ptitsyn OB, Finkelstein AV. 1983. Theory of protein secondary structure and algorithm of its prediction. Biopolymers 22:15-25.
40. Ray R, Khanna A, Lagging LM, Meyer K, Choo QL, Ralston R, Houghton M, Becherer PR. 1994. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J Virol 68:4420-4426.
41. Riezu-Boj JI, Parker D, Civeira MP, Phoppard D, Corbishley TP, Camps J, Castilla A, Prieto J. 1992. Detection of hepatitis C virus antibodies with new recombinant antigens: assessment in chronic liver diseases. J Hepatol 15:309-313.
42. Sallberg M, Ruden U, Wahren B, Magnius LO. 1992. Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J Clin Microbiol 30:1989-1994.
43. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular Cloning. New York: Cold Spring Harbor Laboratory Press.
44. Selby MJ, Choo QL, Berger K, Kuo G, Glazer E, Eckart M, Lee C, Chien D, Kuo C, Houghton M. 1993. Expression, identification and subcellular localization of the proteins. J Gen Virol 74:1103-1113.
45. Simmonds P. 1995a. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5, and 6. J Gen Virol 76:1737-1748.
46. Simmonds P. 1995b. Variability of hepatitis C virus. Hepatology 21: 570-583.
47. Simmonds P, Holmes EC, Cha T-A, Chan S-W, McOmish F, Irvine B, Beall E. 1993a. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J Gen Virol 74:2391-2399.
48. Simmonds P, Rose KA, Graham S, Chan S-W, McOmish F, Dow BC, Follett EAC, Yap PL, Marsden H. 1993b. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV. use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Mocrobiol 31:1493-1503.
49. Smith DB, Johnson KS. 1988. single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione s-transferase. Gene 67:31-40.
50. Srinivasappa JJ, Saegusa J, Prabhakar BS, Gentry MK, Buchmeier MJ, Wiktor TJ, Koprowski H, Oldstone MBA, Notkins AL. 1986. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol 57:397-401.
51. Stuyver L, Van Arnhem W, Wyseur A, Maertens G. 1994. Cloning and phylogenetic analysis of the core, E2, and NS3/NS4 regions of the hepatitis C virus type 5a. Biochem Biophys Res Commun 202: 1308-1314.
52. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65:1105-1113.
53. Takeuchi K, Kubo Y, Boonmar Y, Waranabe Y, Katayama T, Choo QL, Kuo G, Houghton M, Saito E, Miyamura T. 1990. The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. J Gen Virol 71:3027-3033.
54. Trujillo JR, Mclane MF, Lee TH, Essex M(1993. Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain protein. J Virol 67:7711-7715.
55. Van Der Poel CL, Cuypers HT.M, Reesink HW, Weiner AJ, Quan S, Di Nello R, Van Boven JJP, Winkel I, Mulder-Folkerts, D, Exel-Oehers PJ, Schaasberg W, Leentvaar-Kuypers A, Polite A, Houghton M, Lelie PN. 1991. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 337: 317-319.
56. Weiner AL, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F. 1991. Variable and hypervariable domains are found in the regions of HCV corresponding to the lavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180:842-848.
57. Wienhues U, Ihlenfeldt H, Seidel C, Schmitt U, Kraas W, Jung G. 1998. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies. Virology 245:281-288.
58. Yagi S, Kashiwakuma T, Yamaguchi K, Chiba Y, Ohtsuka E, Hasegawa A. 1996. An epitope chimeric antigen for the hepatitis C virus serological screening test. Bio Pharm Bull 19:1254-1260.
59. Yuki N, Hayashi N, Mita E, Hagiwara H, Oshita M, Ohkawa K, Katayama K, Kasahara A, Fusamoto H, Kamada T. 1995. Clinical characteristics and antibody profiles of chronic hepatitis C patients: relation to hepatitis C virus genotypes. J Med Virol 45:162-167.
60. Zein NN, Rakela J, Persin DH. 1995. Genotype-dependent serologic reactivities patients infected with hepatitis C virus in the United States. Mayo Clin Pro 70: 449-452.
61. Zein NN, Germer JJ, Went NK, Schimek CM, Thorvilson JN, Mitchell PS, Persing DH. 1997. Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes. J Clin Microbiol 35:311-312.
62. Zhang ZX, Yun Z, Chen M, Sonnerborg A, Sallberg M. 1995. Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction. J Med Virol 45:50-55.